|
Dr. Molinoff, a neuropharmacologist with an M.D. from Harvard, and since November 2003 has been the Vice Provost for Research at the University of Pennsylvania. He holds a faculty position in the Department of Pharmacology and was the A.N. Richards Professor of Pharmacology at the University of Pennsylvania. He is also an Adjunct Professor of Physiology and Neuroscience at the Medical University of South Carolina, Charleston, SC. In addition to his faculty appointments from January 1995 until March 2001, Dr. Molinoff was the Vice President - Neuroscience and Genitourinary Drug Discovery at Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, where he was responsible for implementing and directing the Institute's research efforts in multiple therapeutic areas. He established a multidisciplinary structure to facilitate rapid development of drugs directed against a variety of therapeutic targets across a broad spectrum of neurologic, psychiatric and genitourinary diseases, including stroke, depression, sleep disorders, obesity, Alzheimer's disease, analgesia and neuropathic pain, urinary incontinence and erectile dysfunction. From September 2001 until November 2003, Dr. Molinoff served as Executive Vice President of Research and Development at Palatin Technologies, Edison, NJ, where he was responsible for all basic, preclinical and clinical research. Programs included the recently approved NeuroSpect for imaging infection including equivocal appendicitis and PT-141, a melanocortin agonist being developed for the treatment of sexual dysfunction. Dr. Molinoff has been a member of the Board of Directors of Palatin Technologies since November 2001. He is a member of multiple editorial advisory boards for scientific and educational journals and has authored or edited 6 books including Basic Neurochemistry and Goodman and Gilman's text, The Pharmacological Basis of Therapeutics, as well as over 225 manuscripts. | 